Denis Drygin Regulus Therapeutics Inc. (RGLS) insider trading activity

RGLS Quotes by TradingView

Denis Drygin is Chief Scientific Officer of Regulus Therapeutics Inc.. Currently has a direct ownership of 100,000 shares of RGLS, which is worth approximately $147,000. The most recent transaction as insider was on Mar 01, 2022, when has been sold 76,686 shares (Common Stock) at a price of $0.23 per share, resulting in proceeds of $17,638. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 100K
0% 3M change
0% 12M change
Total Value Held $147,000

Denis Drygin Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 01 2022
BUY
Open market or private purchase
$17,638 $0.23 p/Share
76,686 Added 43.4%
100,000 Common Stock
Feb 04 2022
BUY
Open market or private purchase
$5,362 $0.23 p/Share
23,314 Added 50.0%
23,314 Common Stock
DD

Denis Drygin

Chief Scientific Officer
San Diego, CA

Track Institutional and Insider Activities on RGLS

Follow Regulus Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RGLS shares.

Notify only if

Insider Trading

Get notified when an Regulus Therapeutics Inc. insider buys or sells RGLS shares.

Notify only if

News

Receive news related to Regulus Therapeutics Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RGLS